⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | DSP Value Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | DSP MF | HDFC MF |
| Category | Equity - Value Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹23.73 (29 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Abhishek Singh | Nikhil Mathur |
| Inception | 10 Dec 2020 | 04 Oct 2023 |
| Returns | ||
| 1Y | 0.33% | 22.64% |
| 3Y | 16.32% | 30.41% |
| 5Y | 12.19% | — |
| Since Inception | 15.74% | 29.15% |
| Risk | ||
| 10.64 | 14.07 | |
| 0.71 | 0.59 | |
| 0.88 | 1.59 | |
| 6.63 | 21.67 | |
| 1.80 | 3.48 | |
| -7.27% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.55% | 1.03% |
| Exit Load | NIL upto 10% of units and 1% for remaining units on or before 1M, NIL after 1M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
DSP MF95%
HDFC MF95%
4.7%Only 4.7% of holdings by weight are common between DSP MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingDSP MFHDFC MF
Alkem Laboratories Ltd.2.43%4.64%
Cipla Ltd.2.29%4.15%
Category context: Equity vs Equity. Open the full Screener →